Cancer MoonShot 2020 will arm oncologists with new tools October 30, 2016 By Karen Appold The Cancer MoonShot 2020 program brings together stakeholders from pharma, community and academic oncology, as well as government and scientific communities in an effort to accelerate the potential of combination immunotherapy as the next-generation standard of care in cancer patients. Insurers benefit from getting on board with Cancer MoonShot 2020 October 29, 2016 By Karen Appold Drugs will be provided to health plan members on clinical trials free of charge. New cancer care approach: Highmark’s cancer collaborative October 24, 2016 By Rachael Zimlich RN Cancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration. Obama’s precision medicine initiative: an update October 22, 2016 By Judy Packer-Tursman The precision medicine effort could dramatically change patient care, but will it be effective? Four ways the genomic data commons will advance cancer care October 20, 2016 By Donna Marbury A new cancer database, the Genomic Data Commons, aims to make research more accessible Health execs: How I feel about healthcare’s future October 18, 2016 By Tracey Walker We asked executives how they feel about the future of healthcare. Here’s what they said. Payers Can Help with the Joy of Medicine Payers have a direct interest in preserving independent physician practices and
helping all physicians regain the Joy of Medicine. Four ways clinical decision support can improve outcomes October 14, 2016 By Keren Ofri MD The advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are. Three ways to rein in drug costs regardless of who becomes president October 13, 2016 By Marc O'Connor It’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation. Are oncology pathways effective? AMCP presenters weigh in October 07, 2016 By Aubrey Westgate Faced with a proliferation of oncology treatments, payers have started using oncology pathways. But what do these programs look like, and are they really working?